Format

Send to

Choose Destination
Bioorg Med Chem Lett. 1998 Oct 20;8(20):2839-44.

MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

Author information

1
DuPont Pharmaceuticals Company, Chemical and Physical Sciences Department, Wilmington, DE 19880, USA.

Abstract

In search of antiinflammatory drugs with a new mechanism of action, U0126 was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with an IC50 of 0.07 microM for MEK 1 and 0.06 microM for MEK 2. U0126 can undergo isomerization and cyclization reactions to form a variety of products, both chemically and in vivo, all of which exhibit less affinity for MEK and lower inhibition of AP-1 activity than parent, U0126.

PMID:
9873633
DOI:
10.1016/s0960-894x(98)00522-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center